About the Partnership for Safe Medicines India
The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit www.safemedicinesindia.in
PSM India 17th March Newsletter
Happy New year

News Archive
Editor's Emulsion

Its that time of the year again…to bid adieu to 2013 and welcome 2014 with a new spirit, new hopes and new resolutions.
Wishing all our readers and their family A HAPPY, COLOURFUL AND SAFE HOLI ! May the colours of Auspicious red, Sunkissed gold, Pretty pink, Blissful blue and Forever green fill your lives with brightness and cheer.
Lets go organic this holi and abstain from chemical colours .

If you have any suggestions, comments or queries, please email me at pooja@safemedicinesindia.in.
You may find our previous issues on our website www.safemedicinesindia.in or in the NEWS ARCHIVE section of every PSM NEWZ issue , in case you’ve missed any of them. You may also look us up on Facebook .

Call PSM India toll free helpline 1800 - 11- 4424, to bring cases of spurious medicines or any kind of adverse drug reaction to the notice of the authorities.
Please visit our website www.safemedicinesindia.in if you wish to learn about us .
To register a complaint kindly visit our consumer redressal website www.consumerconexion.org

Happy Reading !
Stay Safe. Stay Healthy !

Pooja Khaitan
Chief Editor ,
Partnership for Safe Medicines India.

Dose of the day

Abdul kalam
"There are several science and technology measures, which have been successfully developed and are cost effective. These technologies can be easily integrated to provide a viable solution to the fake drug menace.These innovations can be the change agent to defeat social criminals who blatantly duplicate products wrongfully, causing great harm to people at large.”
Former President of India, His Excellency, Dr.A.P.J.Abdul Kalam

Upcoming Events

PSM's 5th annual conference will be held on September 18, 2014 at the KnightConference Center at The Newseum, 555 Pennsylvania Av., NW, Washington, D.C.
Each year, the PSM Interchange brings together policymakers, pharmaceutical manufacturers, patient advocates, law enforcement, healthcare professionals, and anti-counterfeiting companies to discuss the problem and solutions to the global scourge of pharmaceutical counterfeiting.
Tickets on sale from March 15.
Click Here to know more

National Injections
‘Miracle doctor’ booked after FDA busts him for TV advertisements
MUMBAI, March 2014: The Food and Drug Administration on Friday filed an FIR against 'miracle doctor' Munir Khan after television advertisements claiming his 'Body Revival' medicine cured cancer, tuberculosis, diabetes and other life threatening diseases resurfaced. Last year, the Bombay High Court had allowed the sale of his medicine on condition that he should not 'exaggerate its benefits'. The FDA claimed that Khan's new advertisements are violating the HC's diktat.
Read More
Haryana unearths cough syrup diversion to Bangladesh
CHANDIGARH, March 2014: In a crackdown against abuse of medicinal intoxicants, Haryana's Food and Drugs Administration (FDA) Sunday said it has unearthed illicit diversion and transportation to Bangladesh of huge quantities of a cough syrup made and sold by a multinational pharmaceutical giant.

Read More
Drug store partners fined
MANGALORE, 2014: The Sullia JMFC court on Wednesday fined partners of a medical store Rs 40,000 for selling drugs without a licenced pharmacist and also substituting the drug. The court held guilty partners of Sai Ganesh Medicals, Sullia, Hubert Ronald D'Souza and Cecilia Mildred D'Souza and sentenced them till rising of the court after imposing the fine.
Read More
Nine-month-old dies after polio vaccination
JAIPUR, 2014: A nine-month-old infant died within minutes of swallowing polio drops in Bhilwara district on Sunday triggering panic among the villagers. An anganwadi worker administered polio drops to several children in Itunda village in Jahajpura tehsil under the national immunization day programme when the newborn, Rohit Raigar, who swallowed polio drops, died within minutes.
Read More
Maharashtra FDA urges MSPC to cancel registrations of pharmacists for doing dual employment
MUMBAI, March 2014: Maharashtra Food and Drug Administration (FDA) has written a letter to the Maharashtra State Pharmacy Council (MSPC) to cancel registrations of 10 offending pharmacists against whom FIRs were lodged for pursuing dual employment and putting patient safety at risk. MSPC Executive Committee has quasi judicial powers to take action against the offending pharmacists ranging from issuing warning letters to cancellation of registration as per section 36 of the Pharmacy Act, 1948.
Read More
Drug Law and Policy Injections
Special surveillance drive by CDSCO on manufacturing sites report 2.3% samples only substandard quality

NEW DELHI, March 2014: A special drive of surveillance on manufacturing sites by the Central Drugs Standard Control Organisation (CDSCO) spread across the country has found that only little above two per cent of drug samples were of not-standard quality while no spurious drug could be traced. The results also showed that Jammu region emerged as the top hub for substandard drugs, going by the results of tests of samples collected through special drive from manufacturing sites and also the joint raids by the CDSCO and the state authorities in hospitals and chemist shops.

Read More
Ministry of Chemicals reconstitutes Pharmaceutical Advisory Forum

NEW DELHI, March 2014: The Ministry of Chemicals and Fertilisers has reconstituted the Pharmaceutical Advisory Forum that will give work as a platform to discuss the issues in the pharma sector among the stakeholders and advise the Department of Pharmaceuticals in policy making efforts.

Read More
Global Injections
PSM's Executive Director Scott A. LaGanga Applauds The Recent Congressional Hearing On Counterfeit Medicine

In his op-ed featured in The Hill on March 1, 2014, LaGanga anticipated that the hearing, Counterfeit Drugs, Fighting Illegal Supply Chains will spark new efforts by the government to educate patients and take stronger action to stop this growing health threat. He encouraged policymakers to better understand the real nature of the threats posed counterfeit drugs, and cited several recent incidents to illustrate how drug counterfeiting is a growing problem.

Read More
Pharma Injections
Investigational drug may increase survival for some patients with advanced melanoma

MARCH 2014 : An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.

Read More
Pradaxa® (dabigatran etexilate) now approved in more than 100 countries for stroke prevention in atrial fibrillation

More than 100 countries have now approved Boehringer Ingelheim's Pradaxa® for the prevention of stroke and systemic embolism for adult patients with the most common sustained heart rhythm condition (non-valvular atrial fibrillation, nvAF).(1) The 100th approval was announced by the Jordan Food and Drug Administration.

Read More
Global Injections
WHO clarifies false media reports on India’s spurious drug percentage

There have been some baseless, irresponsible and malicious claims in the press stating, “WHO estimates that 1 in 5 drugs made in India is a fake” and “10% to 25% of drugs in India are spurious .” However, the fact is that the WHO had clarified as recently as on August 31 2012 that there was no such study carried out by the WHO.

Read More
This Newsletter brought to you by

Jan Aushadhi Logo

© 2011 Partnership for Safe Medicines India F-9, 2nd floor, Kailash Colony, New Delhi -110048
www.safemedicinesindia.in; www.safemedicines.org; www.ConsumerConexion.org
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .PSM India may not be held responsible for any article published in PSM NEWZ .